GL-V9 Inhibits the Activation of AR-AKT-HK2 Signaling Networks and Induces Prostate Cancer Cell Apoptosis through Mitochondria-Mediated Mechanism

Researchers investigated the anti-prostate cancer effect of a drug candidate named GL-V9 and highlight the significant mechanism involving the AKT-HKII pathway.